BDNF and hypersomnia: We hypothesize the following: (1) increases in BDNF but decreases in pro-inflammatory cytokines will be associated with improvements in self-reported insomnia and hypersomnia and (2) baseline levels of these biomarkers will predict improvements in self-reported insomnia and hypersomnia.